Early best supportive care and quality of life trajectories in breast cancer: A multivariate analysis of treatment response patterns.

H Himanshu Varshney (All India Institute of Medical Sciences (AIIMS), Delhi, India) P Prateek Maurya (All India Institute of Medical Sciences (AIIMS), New Delhi, India) N Nishkarsh Gupta A Atul Batra A Ajay Gogia (Department of Medical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India) B Brajesh Kumar Ratre (All India Institute of Medical Sciences (AIIMS), New Delhi, India) S Sachidanand Jee Bharati (All India Institute of Medical Sciences (AIIMS), New Delhi, India) V Vinod Kumar R Rakesh Garg R Rajiv Kumar Malhotra (All India Institute of Medical Sciences (AIIMS), New Delhi, India) S Seema Mishra S Sushma Bhatnagar

Abstract

29 Background: Early integration of palliative care may modify quality of life (QoL) trajectories in cancer patients, but multivariate evidence on treatment response heterogeneity remains limited. Methods: Prospective RCT (N=110) allocating breast cancer patients to early best supportive care (n=56) or on-demand palliative care (n=54). Primary outcomes: Global Health Status (GHS) via EORTC QLQ-C30 and Total Symptom Distress Score (TSDS) via ESAS at baseline and 3-month follow-up. Analysis: Repeated Measures ANOVA, ANCOVA adjusting for baseline covariates, MANOVA on six functional domains, and sensitivity analyses (LOCF, worst-case, per-protocol). Cohen's d with 95% CI reported. Results: 94 patients (85.5%) completed 3-month assessments. Time x Group interactions were significant for GHS (F=4.47, p=0.037) and TSDS (F=4.87, p=0.030). ANCOVA: GHS +6.19 points (95% CI: 0.5-11.9, p=0.034); TSDS -7.14 points (95% CI: -9.1 to -5.1, p<0.001). MANOVA confirmed multivariate QoL restructuring (Pillai's Trace=0.307, F=6.42, p<0.001). Large effects for Social Functioning (d=1.21, p<0.001), medium for Physical Functioning (d=0.66, p=0.002) and Fatigue (d=-0.55, p=0.017). Reliable improvement (Jacobson-Truax): 44.6% vs 14.8% (p=0.003); clinical recovery: 39.3% vs 5.6% (p<0.001). See table. Conclusions: Early best supportive care integration produces statistically significant and clinically meaningful QoL improvements with heterogeneous treatment response patterns. Subgroup analyses suggest selective benefit for patients on active treatment and with shorter disease duration. Clinical trial information: CTRI/2021/06/034136. Primary and secondary outcome measures at 3-month follow-up. Outcome Intervention Control p-value Cohen's d GHS Change +23.2 ± 22.0 +14.7 ± 15.6 0.037 0.44 TSDS Change -28.3 ± 15.7 -21.1 ± 15.6 0.030 0.46 Social Functioning +25.5 ± 22.9 -3.9 ± 25.9 <0.001 1.21 Physical Functioning +18.4 ± 16.5 +6.8 ± 18.9 0.002 0.66 Fatigue -23.1 ± 22.9 -10.3 ± 23.2 0.017 -0.55

Article Details

Volume / Issue Vol. 44, Issue 19_suppl
Published July 01, 2026
Pages 29-29
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (12)

H

Himanshu Varshney

All India Institute of Medical Sciences (AIIMS), Delhi, India

P

Prateek Maurya

All India Institute of Medical Sciences (AIIMS), New Delhi, India

N

Nishkarsh Gupta

A

Atul Batra

A

Ajay Gogia

Department of Medical Oncology, Dr BRA-IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India

B

Brajesh Kumar Ratre

All India Institute of Medical Sciences (AIIMS), New Delhi, India

S

Sachidanand Jee Bharati

All India Institute of Medical Sciences (AIIMS), New Delhi, India

V

Vinod Kumar

R

Rakesh Garg

R

Rajiv Kumar Malhotra

All India Institute of Medical Sciences (AIIMS), New Delhi, India

S

Seema Mishra

S

Sushma Bhatnagar